NCT07265700

Brief Summary

100 patients with mild to moderate urinary incontinence will be randomly divided into two groups. One half will receive functional magnetic stimulation with the Tesla Chair for three months, while the other half will be treated with pelvic floor physiotherapy for the same period. After three and six months, a comparison will be made to determine which patient groups experience an improvement in urinary incontinence and how their muscle strength improves.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
32mo left

Started Jan 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Jan 2026Dec 2028

First Submitted

Initial submission to the registry

November 17, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 5, 2025

Completed
27 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

December 5, 2025

Status Verified

November 1, 2025

Enrollment Period

2.4 years

First QC Date

November 17, 2025

Last Update Submit

November 24, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in ICIQ-SF UI Score

    Change in the International Consultation on Incontinence Questionnaire - Short Form for Urinary Incontinence (ICIQ-SF UI) score from baseline to 3 months after treatment; 1-5= slight incontinence, 19-21= very severe incontinence

    3 months post-treatment (6 months from baseline)

  • Change in ICIQ-SF UI Score

    Change in the International Consultation on Incontinence Questionnaire - Short Form for Urinary Incontinence (ICIQ-SF UI) score from baseline to 6 months after treatment

    6-months post-treatment (9 months from baseline)

Secondary Outcomes (2)

  • Change in pelvic floor muscle strength, measured by the Oxford Scale

    3 months post-treatment (6 months from baseline)

  • Change in pelvic floor muscle strength, measured by the Oxford Scale

    6 months post-treatment (9 months from baseline)

Study Arms (2)

Tesla-Chair

EXPERIMENTAL
Device: Tesla-Chair

Pelvicfloor physiotherapy

ACTIVE COMPARATOR
Procedure: Physiotherapy

Interventions

Magnetic stimulation using the Tesla-Chair

Tesla-Chair
PhysiotherapyPROCEDURE

Pelvicfloor physiotherapy

Pelvicfloor physiotherapy

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Urinary incontinence of first or second degree
  • Written informed consent
  • German speaking (Study information and IC available only in German)

You may not qualify if:

  • Pregnancy or desire to become pregnant
  • Urinary incontinence of third degree
  • Third or fourth degree pelvic organ prolapses
  • no noticeable voluntary muscle activity according to Oxford = O/5
  • Genital infections
  • Malignant tumors
  • Severe neurological diseases
  • Cardiac arrhythmia
  • Active internal medical devices e.g. cardiac pacemakers, medication pumps etc.
  • Ferromagnetic implants at or near the site of stimulation
  • Recent surgery at the site of stimulation
  • Thrombosis or thrombophlebitis
  • Epilepsy or suspected epilepsy
  • Acute stages of kidney stones
  • Gastrointestinal and internal disease at the site of stimulation
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Urinary Incontinence

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2025

First Posted

December 5, 2025

Study Start

January 1, 2026

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

December 5, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share